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Summary
Thirty-two unrelated patients with features of Saethre-
Chotzen syndrome, a common autosomal dominant
condition of craniosynostosis and limb anomalies, were
screened for mutations in TWIST, FGFR2, and FGFR3.
Nine novel and three recurrent TWIST mutations were
found in 12 families. Seven families were found to have
the FGFR3 P250R mutation, and one individual was
found to have an FGFR2 VV269–270 deletion. To date,
our detection rate for TWIST or FGFR mutations is
68% in our Saethre-Chotzen syndrome patients, includ-
ing our five patients elsewhere reported with TWIST
mutations. More than 35 different TWISTmutations are
now known in the literature. The most common phe-
notypic features, present in more than a third of our
patients with TWIST mutations, are coronal synostosis,
brachycephaly, low frontal hairline, facial asymmetry,
ptosis, hypertelorism, broad great toes, and clinodactyly.
Significant intra- and interfamilial phenotypic variability
is present for either TWIST mutations or FGFR muta-
tions. The overlap in clinical features and the presence,
in the same genes, of mutations for more than one
craniosynostotic condition—such as Saethre-Chotzen,
Crouzon, and Pfeiffer syndromes—support the hypoth-
esis that TWIST and FGFRs are components of the same
molecular pathway involved in the modulation of cran-
iofacial and limb development in humans.
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Introduction
Saethre-Chotzen syndrome (acrocephalosyndactyly type
III; MIM 101400 [Saethre 1931; Chotzen 1932]) is one
of the most common inherited conditions, with both
premature fusion of the calvarial bones (craniosynosto-
sis) and limb abnormalities. The inheritance pattern of
Saethre-Chotzen syndrome is autosomal dominant with
high penetrance and variability of expression. The es-
timated birth prevalence is 1/25,000–1/50,000 and, be-
cause the phenotype can be mild, is probably underdi-
agnosed. In individuals without limb abnormalities, it is
sometimes difficult to differentiate between Saethre-
Chotzen syndrome and Crouzon syndrome, another cra-
niosynostosis condition. The notable craniofacial char-
acteristics of Saethre-Chotzen syndrome are facial asym-
metry, hypertelorism, and ptosis (fig. 1). The most
common limb abnormalities are brachydactyly, broad
great toes, and cutaneous syndactyly.
Chromosomal rearrangements (Reardon et al. 1993;
Reid et al. 1993; Lewanda et al. 1994; Rose et al. 1994;
Tsuji et al. 1994; Wilkie et al. 1995b) and linkage anal-
ysis (Brueton et al. 1992; Lewanda et al. 1994; van Her-
werden et al. 1994) have mapped the locus for Saethre-
Chotzen syndrome to chromosome 7p21-p22. A
candidate gene, TWIST, the human homologue of the
Drosophila twist gene, recently has been localized to this
same region (Bourgeois et al. 1996; Howard et al. 1997)
and has been shown to contain mutations in Saethre-
Chotzen syndrome patients (El Ghouzzi et al. 1997b;
Howard et al. 1997). The TWIST gene contains a basic
helix-loop-helix (bHLH) motif that suggests that the
TWIST gene product acts as a transcription factor. The
HLH region of this motif is important for homo- or
heterodimerization, whereas the basic domain is essen-
tial for binding of the dimer complex to a target DNA-
binding sequence(s). Elsewhere, TWIST mutations have
been reported in a total of 12 of 25 apparently unrelated
individuals with Saethre-Chotzen syndrome (El Ghouzzi
Figure 1 Photographs of Saethre-Chotzen syndrome patients. Note brachycephaly, facial asymmetry, midface hypoplasia, ptosis, hyper-
telorism, and/or downward-slanting palpebral fissures. A–E, Individuals with TWIST mutations: FSCSJP101 (A), FSCSJN77 (B), FSCSRM1403
(C), and FSCSMK1401 (D), who has acrobrachycephaly and deformational changes, and FSCSJW1402 (E), relative of a family reported by
Jones [1997]). F, FGFR2 mutation found in individual FSCSIN95. The bottom row shows first cousins who have the FGFR3 P250R mutation.
G, Saethre-Chotzen syndrome–like phenotype, with ptosis and downward-slanting palpebral fissures. H, Crouzon syndrome–like phenotype,
with mild ocular proptosis and prognathism.
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Table 1
Oligonucleotides for PCR Amplification and Mutation Detection






TWIST 1 GAGGCGCCCCGCTCTTCTCC AGTCTCCTCGTAAGACTGCGGAC 378 64 Howard et al. (1997)
TWIST 1 CAAGAAGTCTGCGGGCTGTG AATCGAGGTGGACTGGGAACCG 512 67 Howard et al. (1997)
FGFR2 IIIa TGACAGCCTCTGACAACACAAC GGAAATCAAAGAACCTGTGGC 350 62 Park et al. (1995b)
FGFR2 IIIc CACAATCATTCCTGTGTCGT AACCCAGAGAGAAAGAACAGTA 225 58 Jabs et al. (1994)






TWIST 309CrG GCAGTCTTAGGAGGAGCTG 50 GCAGTCTTACGAGGAGCT 55
TWIST 384insC AGGCGTTCCGCCGCGCT 55 AGGCGTTCGCCGCGCT 50
TWIST 415CrT CACGCTGTCCTCGGACAA 67 CACGCTGCCCTCGGACAA 67
TWIST 421GrT TGCCCTCGTACAAGCTGA 58 TGCCCTCGGACAAGCTGA 60
TWIST 445CrT AGATTCAGACCTTCAAGCT 55 AGATTCAGACCCTCAAGCT 54
a Of annealing step during amplification.
b The mutation is denoted by underlining.
et al. 1997b; Howard et al. 1997). Although mutations
were found in 48% of the patients, the fact that mu-
tations were not detected in all affected individuals sug-
gests genetic heterogeneity in patients with the Saethre-
Chotzen phenotype. Among the chromosomal rear-
rangements associated with Saethre-Chotzen syndrome,
the breakpoint in one patient was reported to map 5 kb
3′ from TWIST, indicating the possible presence of a
regulatory region downstream of the gene (Krebs et al.
1997).
Because Drosophila twist affects the expression of a
fibroblast growth-factor receptor (FGFR) homologue,
DFR1 (Shishido et al. 1993), and because mutations in
human FGFRs have been reported in patients with cra-
niosynostosis (Park et al. 1995a; Bellus et al. 1996), we
have chosen to evaluate FGFRs as additional loci for
Saethre-Chotzen syndrome. Here we report the identi-
fication of novel mutations in TWIST and of mutations
in FGFR2 and FGFR3 in patients with features of Sae-
thre-Chotzen syndrome. These results suggest that
FGFRs may be in the same developmental pathway as
TWIST and that, between Drosophila and humans, there
is conservation of this pathway.
Patients and Methods
Patient Population
All probands and family members (in the present study
and in our previous report [Howard et al. 1997]) were
clinically examined by a medical geneticist/dysmor-
phologist, and the frequencies of their features were tab-
ulated. Genomic DNA was isolated from blood samples
or cultures (lymphoblast, osteoblast, or fibroblast) from
32 unrelated Saethre-Chotzen syndrome patients and
their relatives and from 100 controls, by means of a
Blood and Cell Culture DNA kit (Qiagen).
PCR Amplification of TWIST, FGFR2, and FGFR3
The coding region of TWIST was amplified by use of
two sets of primers, as reported elsewhere (Howard et
al. 1997). The two PCR products contain sequence from
nucleotide61 to nucleotide317 and from nucleotide
225 to nucleotide 736 (where the start codon is 1)
of the TWIST gene (Howard et al. 1997). Exon IIIa of
FGFR2, exon IIIc of FGFR2, and exon 7 of FGFR3
were amplified by use of primers derived from the se-
quence in our laboratory, as described elsewhere (by
Park et al. [1995b], Jabs et al. [1994], and Bellus et al.
[1996], respectively). PCR reactions were performed in
50-ml volumes with 100–500 ng genomic DNA, 10 mM
TrisHCl (pH 8.3), 1.5 mM MgCl2, 50 mM KCl, 0.2 mM
each dNTP, 0.5 mM each primer, with or without 10%
dimethyl sulfoxide, and 2 U Taq DNA polymerase
(Boehringer Mannheim). PCR parameters were 94C for
5 min; 35 cycles of 94C for 40 s, annealing temperature
for 40 s, and 72C for 40 s; and 72C for 3 min. Primers,
PCR product size, and annealing-temperature conditions
are provided in table 1.
Mutation Detection
TWIST PCR products were run on 2% NuSieve (FMC
BioProducts) gels and were extracted. The DNA, iso-
lated by a Gel Extraction kit (Qiagen), was directly se-
quenced in both directions by the Johns Hopkins Genetic
Resources Core Facility, with use of the specific PCR
primers. Mutations were confirmed by restriction-en-
zyme digestion or allele-specific hybridization. Restric-
tion-enzyme digestions were performed under conditions
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Table 2










Mutation Functional Domain Reference
11213 ) 181GrT G61STOP Nonsense Prior to DNA binding Rose et al. (1997)
11795 ) 193GrT E65STOP Nonsense Prior to DNA binding Rose et al. (1997)
G601 ) 232TrC S78P Missense Prior to DNA binding Rose et al. (1997)
FSCSLC75 MseI 308insA Y103STOP Nonsense Prior to DNA binding Howard et al. (1997)
FSCSJM MseI 308insA Y103STOP Nonsense Prior to DNA binding Present study
NA ) 309CrAc Y103STOPc Nonsense Prior to DNA binding El Ghouzzi et al. (1997b)
FSCSJN77 ASO 309CrG Y103STOP Nonsense Prior to DNA binding Present study
FSCSPL1487 ASO 309CrG Y103STOP Nonsense Prior to DNA binding Present study
NA ) 310GrT E104STOP Nonsense Prior to DNA binding El Ghouzzi et al. (1997a)
FSCSRM1403 AflIII 346CrT R116W Missense DNA binding Present study
NA ) 352del3 R118Q Deletion DNA binding El Ghouzzi et al. (1997a)
12525 ) 353GrA R118H Missense DNA binding Rose et al. (1997)
FSCSAGF14 BstUI 356ArC Q119P Missense DNA binding Howard et al. (1997)
FSCSFL BfaI 364CrT Q122STOP Missense Helix I Present study
NA ) 368CrAc S123STOPc Nonsense Helix I El Ghouzzi et al. (1997b)
NA ) 376GrTc E126STOPc Nonsense Helix I El Ghouzzi et al. (1997b)
20556 ) 376GrT E126STOP Nonsense Helix I Rose et al. (1997)
FSCSJP101 ASO 384insC A129Rd Frameshift/
elongation
Helix I Present study
NA ) 392TrCc L131Pc Missense Helix I El Ghouzzi et al. (1997b)
FSCSSS1404 BslI 395GrC R132P Missense Helix I Present study
11778 ) 402CrG I134M Missense Helix I Rose et al. (1997)
FSCSKB66 Gel 405dup21 I135ins7(AALRKII) Duplication Helix I Howard et al. (1997)
FICSNH36 ASO 415CrT P139S Missense Loop Present study
FSCSDMJ26 Gel 416dup21 P139ins7(KIIPTLP) Duplication Loop Howard et al. (1997)
NA ) 416dup21c P139ins7(KIIPTLP)c Duplication Loop El Ghouzzi et al. (1997b)
NA ) 416dup21c P139ins7(KIIPTLP)c Duplication Loop El Ghouzzi et al. (1997b)
FSCSJW1402 ) 416dup21 P139ins7(KIIPTLP) Duplication Loop Present study
NA ) 417dup21c P139ins7(KIIPTLP)c Duplication Loop El Ghouzzi et al. (1997b)
G264 ) 417dup21 P139ins7(KIIPTLP) Duplication Loop Rose et al. (1997)
G27 ) 418dup21 S140STOP Nonsense Loop Rose et al. (1997)
11716 ) 420dup21 S140ins7(IIPTLPS) Duplication Loop Rose et al. (1997)
FSCSTR ASO 421GrT D141Y Missense Loop Present study
G440 ) 422ArG D141G Missense Loop Rose et al. (1997)
NA ) 433ArG K145E Missense Loop El Ghouzzi et al. (1997a)
FSCSML31 Gel 433del23 K145Gd Frameshift/
elongation
Loop Howard et al. (1997)
10310 ) 435GrC K145N Missense Loop Rose et al. (1997)
NA ) 443CrA T148N Missense Loop Ray et al. (1997)
FSCSMM1600 ASO 445CrT L149F Missense Loop Present study
FSCSMK1401 MscI 455CrT A152V Missense Loop Present study
G181 ) 460ArG R154G Missense Helix II Rose et al. (1997)
NA ) 475CrT L159F Missense Helix II El Ghouzzi et al. (1997a)
NA ) 481CrT Q161STOP Nonsense Helix II El Ghouzzi et al. (1997a)
a NA  no family-identification number given
b An ellipsis ()) indicates that the method is unknown; and “Gel” indicates that the mutant allele was distinguishable by agarose gel
electrophoresis.
c Numbering has been modified from that of El Ghouzzi et al. (1997b), to be consistent with our own numbering system.
d The change has been represented by indicating both the first amino acid in which the frameshift occurred and the corresponding amino
acid substituted; all subsequent amino acids are altered.
described in the manufacturer’s instructions (Life Tech-
nologies and New England Biolabs). Allele-specific hy-
bridizations were performed as described elsewhere
(Jabs et al. 1994; see tables 1 and 2 and fig. 2). Hy-
bridizations were performed in Rapid-hyb buffer (Amer-
sham) according to the manufacturer’s instructions. The
final posthybridization wash was in 0.2 # SSC/0.1%
SDS. Mutant and normal allele-specific oligonucleotides
(ASOs) and wash temperatures are provided in table 1.
To obtain each allele, PCR products for the TWIST
308insA, 384insC, and 416dup21 mutations and the
FGFR2 983–988delAGTGGT mutation were cloned
Figure 2 Mutations in Saethre-Chotzen syndrome, detected by fluorometric sequencing and either restriction-enzyme digestion or ASO
hybridization. The sequence of each mutant allele is shown above the normal allele sequence, and the mutations are indicated by arrows. The
family designation is to the left of each sequence and corresponds to that used in table 2. The results of restriction-enzyme digestion or ASO
hybridization are shown below the respective sequence; and the patient (P) and control (C) samples are indicated. For ASO hybridization, results
from the mutant oligonucleotides are shown above those from the normal oligonucleotides. The molecular-weight marker on agarose gels is
PhiX174/HaeIII in the left lane of each gel. A–I, TWIST mutations. J, FGFR2 mutation. A, 309CrG mutation detected by ASO hybridization,
from one of the two unrelated patients. B, 346CrT mutation, detected by digestion with restriction enzyme AflIII, which digests the mutant
allele into two fragments, of 117 and 395 bp, and which does not digest the normal allele, which is 512 bp. C, 364CrT mutation, detected
by digestion with restriction enzyme BfaI, which digests the normal allele into fragments of 42, 88, and 382 bp and which digests the mutant
allele into fragments of 42, 88, 139, and 243 bp. The 42-bp fragment is not visible on this gel. D, 384insC mutation, sequenced from a cloned
mutant allele and detected by ASO hybridization. E, 395GrC mutation, detected by digestion with restriction enzyme BslI, which digests the
mutant allele and creates fragments of 1, 18, 23, 25, 30, 60, 106, 120, and 129 bp. The normal allele is digested into fragments of 1, 18, 23,
25, 30, 48, 58, 60, 120, and 129 bp. Fragments !60 bp were not well visualized on the agarose gel. F, 415CrT mutation, detected by ASO
hybridization. G, 421GrT mutation, detected by ASO hybridization. H, 445CrT mutation, detected by ASO hybridization. I, 455CrT mutation,
detected by digestion with restriction enzyme MscI, which digests the mutant allele to create fragments of 113, 120, and 279 bp. The 113- and
120-bp fragments are not separated on this gel. Digestion of the normal allele results in fragments of 113 and 399 bp. J, 6-bp deletion of
FGFR2, detected by sequencing of a cloned mutant allele and by restriction enzyme MspI, which digests the mutant allele to create fragments
of 8, 16, 17, 96, and 206 bp. Digestion of the normal allele results in fragments of 8, 17, 96, and 228 bp. Bands !96 bp are not visualized on
this gel.
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into the vector pCR2.1, by means of a TA Cloning Kit
(Invitrogen). Clones containing the mutant alleles were
distinguished from those with the normal allele, either
by ASO hybridization (Howard et al. 1997), in the case
of the former three mutations, or by MspI digestion and
electrophoresis, in the case of the latter mutation. PCR
amplification products from both normal and mutant
clones were sequenced as described above.
The 749CrG (P250R) FGFR3 mutation was detected
by NciI digestion of the exon 7 PCR fragment. Digestion
of the normal allele produces 218- and 123-bp frag-
ments, whereas the mutant allele produces fragments
that are 67, 151, and 123 bp in size. The mutation was




TWIST was screened for mutations in 32 unrelated
patients with features of Saethre-Chotzen syndrome. We
previously had screened the TWIST coding region by
heteroduplex analysis and direct sequencing (Howard et
al. 1997). Since no common mutations were found in-
itially, all subsequent screening was performed by direct
sequence analysis of the TWIST coding region (GenBank
accession number U80998). We have detected a total of
12 mutations: 9 new and distinct mutations, 1 of which
is present in two unrelated individuals, and 2 mutations
that have been reported elsewhere (El Ghouzzi et al.
1997b; Howard et al. 1997) (table 2 and figs. 2 and 3).
A nonsense mutation (309CrG) was found prior to
the DNA-binding domain, at amino acid position 103
(fig. 2A), in two families. Also, prior to the DNA-binding
domain, an insertion (308insA) coding for a stop codon
that we previously had identified (Howard et al. 1997)
was seen in an additional family (data not shown). An-
other mutation (CrT) detected within the DNA-binding
domain, at nucleotide 346, changes codon 116 from
arginine to tryptophan (fig. 2B).
Three new mutations—two missense mutations
(364CrT, Q122stop [fig. 2C] and 395GrC, R132P [fig.
2E]) and an insertion that causes a frameshift (384insC,
A129R [fig. 2D])—were identified within the helix I do-
main. The frameshift mutation presumably results in a
mutant peptide that extends 86 amino acids farther than
the wild-type protein (160 amino acids after the frame-
shift), resulting in an abnormal protein of 287 amino
acids. Five mutations were detected in the loop domain
of TWIST. One of these, 416dup21, P139ins7(KIIPTLP)
(data not shown), had been reported elsewhere in three
cases (El Ghouzzi et al. 1997b; Howard et al. 1997). Of
historical interest, the affected FSCSJW1402 individual
(fig. 1E) with this mutation is a descendant of the mul-
tigenerational family whose photographs illustrate the
Saethre-Chotzen phenotype described in Smith’s Rec-
ognizable Patterns of Human Malformations (Jones
1997). The remaining four novel changes are missense
mutations (415CrT, P139S [fig. 2F]; 421GrT, D141Y
[fig. 2G]; 445CrT, L149F [fig. 2H]; and 455CrT,
A152V [fig. 2I]). None of these mutations were detected
in 50–100 normal controls.
An FGFR2 mutation with an in-frame, 6-bp, or two-
amino-acid deletion (983–988delAGTGGT, VVdel269–
270) in the linker region between the IgII- and IgIII-like
domains was observed in one patient (figs. 1F and 2J).
A common mutation in the analogous region of FGFR3
recently has been identified in families with various cra-
niosynostosis syndromes, some of whom had pheno-
types consistent with Saethre-Chotzen, Pfeiffer, and
Crouzon syndromes (Bellus et al. 1996; Muenke et al.
1997). This mutation (749CrG, P250R) creates a novel
NciI restriction-enzyme site that was used to screen all
32 unrelated patients, to evaluate the possible role of
FGFR3 in the etiology of Saethre-Chotzen syndrome.
We detected the P250R mutation in seven unrelated pa-
tients diagnosed with Saethre-Chotzen syndrome (data
not shown).
We analyzed our mutation data from a total of 37
patients with features of Saethre-Chotzen syndrome
(Howard et al. 1997; present study); 46% have TWIST
mutations, 19% have FGFR3 mutations, and 3% have
FGFR2 mutations. To date, mutations have been de-
tected in 68% of our patients.
Phenotypic Characteristics of Patients
All patients were clinically diagnosed to resemble Sae-
thre-Chotzen syndrome more than any other craniosyn-
ostosis syndrome. The frequency of each clinical feature
seen in these patients was analyzed. The features present
in 39 affected members of 17 families with TWIST mu-
tations (Howard et al. 1997; present study) and in 10
individuals in 7 families with FGFR3 and 1 family with
FGFR2 mutations are listed in table 3. In patients with
TWIST mutations, craniosynostosis (especially involv-
ing the coronal suture and leading to brachycephaly),
ptosis, or broad great toes occurs in 154% of affected
individuals. The next most common features found in
x33% of patients include low frontal hairline, facial
asymmetry, epicanthal folds, hypertelorism, cutaneous
syndactyly (especially of the second and third digits),
and clinodactyly. The less common features include in-
volvement of the sagittal, lambdoidal, and/or metopic
sutures, in combination with the coronal sutures and
leading to acrobrachycephaly or plagiocephaly, large
fontanelles with or without ossification defects of the
neurocranium (Wormian bones), medially sparse eye-
brows that thicken laterally, down-slanting palpebral fis-
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Figure 3 Alignment of Xenopus, mouse, and human TWIST amino acid sequences and the human TWIST nucleotide sequence. Fifty-six
amino acids from the N-terminal portion and 34 amino acids from the C-terminal portion of the protein are not shown. All mutations that
have been found thus far in the human nucleotide sequence are shown (arrows and brackets). Recurrent mutations are denoted by either larger
font or thicker brackets. Boxes indicate simple repeats that may play a role in causing unequal–crossing-over events and subsequent recurrent
duplications and deletions.
sures, strabismus, ear anomalies (small ears and prom-
inent crus), mild to moderate hearing loss,
brachydactyly, short stature, learning disabilities, and
mental retardation. In fewer than four cases, but present
in more than one individual, are blepharophimosis, mid-
face hypoplasia, malocclusion, cleft palate (also bifid
uvula, or high-arched palate), micrognathia, spinal de-
fects (cervical spine fusions, or kyphosis), hallux valgus,
talocalcaneal coalition of the feet, hypoplastic kidney,
and seizures. None of the features obviously segregated
within families having the same mutations, which would
have suggested distinct phenotype/genotype correla-
Paznekas et al.: TWIST and FGFR Mutations in ACSIII 1377
Table 3
Features of Saethre-Chotzen Syndrome in Individuals with
TWIST or FGFR Mutations
TWIST FGFR2 FGFR3
Age range (years) to 62112 4 years 1 to 41
7
12
Sex ratio (female:male) 20:19 0:1 6:4
Clinical features:a
Karyotype (abnormal) 0/39 (0) 0/1 0/10 (0)
Craniosynostosis:b 25/39 (64) 1/1 5/10 (50)
Coronal 21/39 (54) 1/1 5/10 (50)
Lambdoidal 6/39 (15) 0/1 2/10 (20)
Sagittal 4/39 (10) 0/1 1/10 (10)
Metopic 3/39 (8) 0/1 1/10 (10)
Brachycephaly 23/39 (59) 1/1 5/10 (50)
Acrobrachycephaly 8/39 (21) 0/1 4/10 (40)
Plagiocephaly 9/39 (23) 1/1 1/10 (10)
Large fontanelles 10/39 (26) 0/1 0/10 (0)
Low frontal hairline 14/39 (36) 1/1 2/10 (20)
Facial asymmetry 15/39 (38) 1/1 1/10 (10)
Eyebrow irregularity 7/39 (18) 1/1 0/10 (0)
Ptosis 23/39 (59) 1/1 3/10 (30)
Antimongoloid slant 11/39 (28) 1/1 4/10 (40)
Epicanthal folds 13/39 (33) 0/1 0/10 (0)
Hypertelorism 17/39 (44) 1/1 6/10 (60)
Strabismus 10/39 (26) 0/1 3/10 (30)
Ear anomalies 7/39 (18) 0/1 0/10 (0)
Syndactyly 13/39 (33) 0/1 2/10 (20)
Brachydactyly 8/39 (21) 0/1 3/10 (30)
Broad great toe 21/39 (54) 0/1 2/10 (20)
Clinodactyly 17/39 (44) 0/1 2/10 (20)
Short stature 7/39 (18) 0/1 1/10 (10)
Learning disabilities/
mental retardation
4/39 (10) 0/1 1/10 (10)
Hearing loss 4/39 (10) 0/1 1/10 (10)
a Data are number (%) of Saethre-Chotzen–syndrome indi-
viduals who present a particular feature/total number of affected
members from all families studied who have either TWIST mu-
tation or FGFR mutation
b Frequency may be underreported, because not every indi-
vidual had a computed-tomography scan or radiography.
tions. Although the number of patients in our study was
limited, the clinical features of patients who were re-
ferred with the possible diagnosis of Saethre-Chotzen
syndrome and who were found to have FGFR3 muta-
tions were not obviously different from those of indi-
viduals with TWIST mutations. In addition, it is im-
portant to note that the patient with the FGFR2
mutation had all the features, except digital anomalies,
that occur in x33% of all patients with TWIST mu-
tations (table 3).
Intrafamilial variability was present for TWIST mu-
tations and for FGFR3 mutations, demonstrating the
difficulties in making distinct clinical diagnoses. For ex-
ample, the phenotype of members of one of these fam-
ilies (FSCSLC75) with a previously reported Y103stop
mutation (Howard et al. 1997) was more severe than
the typical Saethre-Chotzen phenotype. In addition to
the common features, family members with this muta-
tion had cleft palate, short stature, and learning disa-
bilities. In two new, unrelated individuals (FSCSJN77
[fig. 1B] and FSCSPL1487) with the same nonsense mu-
tation, however, the phenotype is not as severe, sug-
gesting that environmental factors or modifying genes
contribute to the variability of expression in Saethre-
Chotzen syndrome. In the FSCSMK1401 family with a
missense mutation in the TWIST loop domain, the
mother has a very mild phenotype. However, her affected
child’s phenotype (fig. 1D) was complicated by defor-
mational changes that were due to maternal fibroids. In
one family with an FGFR3 mutation, two branches of
the family (two siblings and their offspring) were eval-
uated, and each was given a different diagnosis, either
Saethre-Chotzen syndrome or Crouzon syndrome (figs.
1G and H).
Discussion
It is generally accepted that genetic heterogeneity ex-
ists in Saethre-Chotzen syndrome. Although linkage-
analysis data and chromosomal rearrangements had sug-
gested a predominant locus on chromosome 7p (Brueton
et al. 1992; Reardon et al. 1993; Reid et al. 1993; Le-
wanda et al. 1994; Rose et al. 1994; van Herwerden et
al. 1994; Wilkie et al. 1995b), other reports of families
that did not have linkage to this locus allowed for spec-
ulation as to the possible involvement of other loci (Ma
et al. 1996; von Gernet et al. 1996). In addition, many
Saethre-Chotzen syndrome patients were found to have
rearrangements outside the critical region on chromo-
some 7p21-p22 (Aughton et al. 1991; Kikkawa et al.
1993).
Recent reports have identified the bHLH putative
transcription factor TWIST as a cause of Saethre-
Chotzen syndrome in families with linkage to chromo-
some 7p21-p22 (El Ghouzzi et al. 1997b; Howard et al.
1997). To date, we have identified 14 distinct TWIST
mutations (Howard et al. 1997; present study), and x21
additional mutations have been reported by others (El
Ghouzzi et al. 1997a, 1997b; Ray et al. 1997; Rose et
al. 1997), so that 135 mutations are now known. Each
of these mutations is predicted either to occur in a highly
conserved region, to alter the key functional domains of
TWIST, or to result in a truncated protein lacking the
entire bHLH region.
Of the mutations reported in this study, the 309CrG
mutation results in a stop codon at residue 103, pre-
sumably resulting in premature termination of the pro-
tein. Interestingly, two additional nonsense mutations
that are different at the nucleotide level have been re-
ported at this same codon (El Ghouzzi et al. 1997b;
Howard et al. 1997). It is predicted that the Y103stop
mutation causes a complete loss of function of TWIST,
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because the portion of the protein required for DNA
binding and dimerization would not be contained within
the mutant protein.
The remaining seven new TWIST mutations were
found in highly conserved functional domains. In this
study, the R116W mutation occurs within the DNA-
binding domain and presumably alters the affinity of the
mutant protein for the DNA target sequence. The ar-
ginine at amino acid 116, as well as all residues in the
DNA-binding domain, is conserved among Drosophila,
Xenopus, mouse, and human (fig. 3; Wang et al. 1997).
The Q122stop mutation occurs in the helix I domain,
which is conserved in all four species and which may
result in a functionally inactive dimerization domain.
The A129R frameshift mutation occurs within the helix
I domain of TWIST, at a residue that is conserved be-
tween mouse and human. All subsequent residues are
presumably changed with this mutation, resulting in a
mutant protein with unknown, if any, function. It is
unlikely that this protein is able to function, because it
would lack half the bHLH domain. The remaining four
mutations, located either in the helix domain, which is
conserved between mouse and humans, or in the loop
domain, which is completely conserved in all four spe-
cies, may alter dimerization and subsequent DNA-bind-
ing properties.
In addition to mutations in TWIST, we also detected
mutations in FGFR2 and FGFR3, two of four known
FGFRs in humans, in individuals with features of Sae-
thre-Chotzen syndrome, as had been reported, in an un-
designated number of cases, by Bellus et al. (1996) and
Muenke et al. (1997), and in one large family, by Golla
et al. (1997). FGFRs play key roles in development, and
mutations in FGFR1, FGFR2, and FGFR3 have been
found in craniosynostosis conditions such as Crouzon
syndrome (Jabs et al. 1994; Reardon et al. 1994), Jack-
son-Weiss syndrome (Jabs et al. 1994), Pfeiffer syndrome
(Muenke et al. 1994; Lajeunie et al. 1995; Rutland et
al. 1995; Schell et al. 1995), and Apert syndrome (Park
et al. 1995b; Wilkie et al. 1995a) (for review, see Park
et al. 1995a). Like Saethre-Chotzen syndrome, these
conditions can have inter- and intrafamilial variability
(Park et al. 1995b; Rutland et al. 1995; Schell et al.
1995). The phenotypic spectrum of Jackson-Weiss syn-
drome in a large Amish kindred includes Saethre-
Chotzen, Crouzon, and Pfeiffer syndromes (Jackson et
al. 1976; Jabs et al. 1994). Also, Crouzon and Pfeiffer
syndromes have been diagnosed in different members
within a single family (Meyers et al. 1996). Both Crou-
zon and Pfeiffer syndromes are similar to Saethre-
Chotzen syndrome, because they are genetically heter-
ogeneous, caused by mutations at three different
loci—FGFR1, FGFR2, and FGFR3. We have detected
the FGFR3 P250R mutation in a total of 10 families
with Crouzon, Pfeiffer, or unclassified craniosynostosis
syndrome (data not shown).
The finding, in the same genes, of mutations for the
craniosynostosis conditions with common clinical fea-
tures suggests that these disease genes are components
of the same developmental pathway where their direct
or indirect interactions could affect the expression of
downstream components. The identification of FGFR2
and FGFR3 mutations also in patients with Saethre-
Chotzen syndrome–like features suggests an interaction
between TWIST and the FGFRs in humans. It has been
suggested that, in Drosophila, twist is required for the
expression of DFR1, an FGFR homologue, in the early
stages of embryogenesis (Shishido et al. 1993). In fact,
twist embryos display phenotypes similar to those seem
in DFR1 embryos (Shishido et al. 1993), providing fur-
ther evidence that these two proteins are involved in the
same developmental pathway. If this same type of in-
teraction occurs in humans, then other FGFRs may also
be involved in the pathogenesis of Saethre-Chotzen syn-
drome. Additional analysis of these genes is necessary
in order to allow study of this possibility.
In conclusion, genetic heterogeneity in Saethre-
Chotzen syndrome appears to be due to at least three
genes—TWIST, FGFR2, and FGFR3. The Saethre-
Chotzen syndrome patients whose mutations have not
been identified may have mutations either in other genes
of the same developmental pathway, in other FGFRs, or
in different domains of FGFR2 or FGFR3. The regu-
latory regions of all of these genes may also contribute
in part to the Saethre-Chotzen phenotype. Additional
screening of these sequences may identify other critical
regions involved in the pathogenesis of Saethre-Chotzen
syndrome and other craniosynostosis syndromes.
To date, the mutations found and the cytogenetic de-
letions encompassing the TWIST gene suggest that loss
of TWIST function is a cause of Saethre-Chotzen syn-
drome. Decreased expression of TWIST may, in turn,
cause decreased levels of FGFR expression, as illustrated
in Drosophila. However, this hypothesis is not consistent
with the published results of in vitro studies using con-
structs with FGFR2 mutations found in various cranio-
synostosis conditions, including Crouzon syndrome.
These latter studies show constitutive activation, rather
than loss of function of this receptor (Neilson and Friesel
1995; Galvin et al. 1996). Perhaps mutant FGFR2 and
mutant FGFR3 may not be regulated in this manner in
Saethre-Chotzen syndrome. TWIST may not regulate
FGFR expression in the same way in humans as it does
in Drosophila. TWIST may be a down-regulator of
FGFRs, and, if TWIST expression then is decreased,
FGFR expression may be activated. Expression assays
of TWIST and FGFRs in craniosynostosis syndrome pa-
tients may give us insights into the complex interaction
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among these genes and developmental pathways in-
volved in craniofacial and limb development in humans.
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